Journal
← Tickers

NUVL

NUVL: аналіз акцій · 1 записів

  1. Nuvalent (NUVL) Jumped ~38% — GSK Is Buying It for $10.6B at $124 a Share
    ·3 хв читання

    Nuvalent (NUVL) Jumped ~38% — GSK Is Buying It for $10.6B at $124 a Share

    Nuvalent surged ~38% on June 9 after GSK agreed to buy the cancer-drug maker for $10.6B, or $124 a share in cash — a ~40% premium. Here is how I read the deal.